Delivery Order SPE2DB22D1017-SPE2DB25FG4JG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,877.85 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a non-set-aside, competitively awarded delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order valued at $15,801.10 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this...
- The Defense Logistics Agency awarded a delivery order valued at $16,220.13 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with a completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded on a competitive basis. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $16,421.59 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract type. The order was competitively awarded without set-aside designation and is scheduled for completion by August 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,603.59 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) under a firm fixed price contract. The order was issued on August 28, 2025, with an ultimate completion date of August 29, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $17,919.22 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on September 13, 2025, with completion expected by September 15, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.08 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packaging) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract...
- The Defense Logistics Agency awarded a delivery order valued at $51,982.18 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the point of performance for this pharmaceutical supply delivery. This delivery order is issued under...
- The Defense Logistics Agency awarded a $17,006.14 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed price contract. The award was issued on July 30, 2025, with a completion date of July 31, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $13,292.70 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The order, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-competitive set-aside transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG4JGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,966.42 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price arrangement. The award was made on June 5, 2025, with an ultimate completion date of June 6, 2025, and carries no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, syringes, and medical devices. As a prime contractor supporting the Defense Health Agency and other government healthcare systems, AmerisourceBergen Drug Corp has demonstrated capability to fulfill federal medical procurement requirements through open competition across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.0k | 6/5/25 |